Reporte zur Charge UG919AC

Symptomtext

both vaccines were given into the left arm; on the next day had swelling left arm, swell 3 times the normal size, began at the top portion and then extended to the fingertip end; Initial information received on 05-Jun-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 73 years old male patient who was administered vaccines Influenza Quadrival A-B High dose HV vaccine [Fluzone High-Dose Quadrivalent] given into the left arm; on the next day had swelling left arm, swell 3 times the normal size, began at the top portion and then extended to the fingertip end. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Tozinameran (Pfizer Biontech Covid-19 vaccine) for Prophylactic vaccination. On an unknown date in Oct-2022, the patient received 0.7ml dose (frequency: once; strength: standard) of suspect Influenza Quadrival A-B High dose HV vaccine of lot UG919AC and expiry: 30-Jun-2023 via intramuscular route in the left arm for immunization. On an unknown date in Oct-2022, the patient developed both vaccines were given into the left arm; on the next day had swelling left arm, swell 3 times the normal size, began at the top portion and then extended to the fingertip end (peripheral swelling) (latency: 1 day) following the administration of Influenza Quadrival A-B High dose HV Vaccine. No lab data was reported. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (both vaccines were given into the left arm; on the next day had swelling left arm, swell 3 times the normal size, began at the top portion and then extended to the fingertip end). At time of reporting, the outcome was Unknown for the event both vaccines were given into the left arm; on the next day had swelling left arm, swell 3 times the normal size, began at the top portion and then extended to the fingertip end.